These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 38824158

  • 1. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L, Wang Y, Wang W, Wang Z.
    Sci Rep; 2024 Jun 02; 14(1):12634. PubMed ID: 38824158
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Machado GP, Araujo GN, Carpes CK, Lech M, Mariani S, Valle FH, Bergoli LCC, Gonçalves SC, Wainstein RV, Wainstein MV.
    Atherosclerosis; 2018 Jul 02; 274():212-217. PubMed ID: 29803159
    [Abstract] [Full Text] [Related]

  • 4. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C, Chen Z, Zhang J, Jin X, Yang M.
    Front Cardiovasc Med; 2022 Jul 02; 9():1050785. PubMed ID: 36620648
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C.
    Cardiovasc Diabetol; 2019 Nov 13; 18(1):150. PubMed ID: 31722708
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
    Zhang S, Diao J, Qi C, Jin J, Li L, Gao X, Gong L, Wu W.
    BMC Cardiovasc Disord; 2018 May 02; 18(1):75. PubMed ID: 29716535
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S, Chen Q, Zhang Z, Chen Y, Hou J, Cui C, Cheng L, Su H, Long Y, Yang S, Qi L, Chen X, Liu H, Cai L.
    Cardiovasc Diabetol; 2022 Jun 24; 21(1):115. PubMed ID: 35751060
    [Abstract] [Full Text] [Related]

  • 12. Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction.
    Liu M, Pan J, Meng K, Wang Y, Sun X, Ma L, Yu X.
    Sci Rep; 2024 Jan 10; 14(1):976. PubMed ID: 38200157
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
    Her AY, Cho KI, Singh GB, An DS, Jeong YH, Koo BK, Shin ES.
    Int J Cardiovasc Imaging; 2017 Oct 10; 33(10):1445-1454. PubMed ID: 28555389
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y, Peng Z.
    Medicine (Baltimore); 2021 Aug 20; 100(33):e26942. PubMed ID: 34414954
    [Abstract] [Full Text] [Related]

  • 17. Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.
    Oh PC, Eom YS, Moon J, Jang HJ, Kim TH, Suh J, Kong MG, Park SD, Kwon SW, Suh SY, Lee K, Han SH, Ahn T, Kang WC.
    BMC Cardiovasc Disord; 2020 Nov 18; 20(1):486. PubMed ID: 33208092
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Chen X, Meng Y, Shao M, Zhang T, Han L, Zhang W, Zhang H, Hai H, Li G.
    Med Sci Monit; 2020 Jan 07; 26():e919300. PubMed ID: 31949123
    [Abstract] [Full Text] [Related]

  • 19. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Ying C, Liu CF, Guo DQ, Du ZR, Wei YJ.
    Clinics (Sao Paulo); 2023 Jan 07; 78():100306. PubMed ID: 37949037
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.